CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma

Communications in Clinical Cytometry

Volumn 34, Issue 1, 1998, Pages 30-35

  Ruiz, Phillip ^a   Mailhot, Sylvain ^a   Delgado, Patricia ^a   Amador, Alexandra ^a   Viciana, Ana L ^a   Ferrer, Luis ^a   Zacharievich, Natalia ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

CD26; Dipeptidyl peptidase IV; T cell lymphoma

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ADOLESCENT; ARTICLE; BINDING AFFINITY; CANCER CELL; CASE REPORT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HEPATOSPLENOMEGALY; HUMAN; IMMUNOPHENOTYPING; MALE; ONTOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ANTIGENS, CD26; BONE MARROW; FATAL OUTCOME; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; LYMPHOMA, T-CELL; MALE; SPLENIC NEOPLASMS;

EID: 0031906561     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19980215)34:1<30::AID-CYTO5>3.0.CO;2-I     Document Type: Article

References (35)

1. Ulmer A, Mattern T, Feller A, Heymann E, Flad HD: CD26 antigen is a surface dipeptidyl peptidase IV (DPP IV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4ELIC7. Scand J Immunol 31:429-435, 1990.
2. Shipp MA, Look AL: Hematopoietic differentiation antigens that are membrane associated enzymes: Cutting is the key! Blood 82:1052-1070, 1993.
3. De Meester I, Vanhoof G, Hendriks D, Demuth HU, Yaron A, Scarpe S: Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes. Clin Chim Acta 210:23-34, 1992.
4. Abbott CA, Baker E, Sutherland GR, McCaughan GW: Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics 40:331-338. 1994.
5. Droz D, Zachar D, Charbit I., Gogusev Chretien JY, Iris L: Expression of human nephron differentiation molecules in renal cell carcinoma Am J Pathol 137:895-905, 1990.
6. Walter R, Simmons WH, Yoshimoto T: Proline specific endo- and exopeptidases. Mol Cell Biochem 30:111-127, 1980.
7. Mattern T, Reich C, Duchrow M, Ansorge S, Ulmer AJ, Flad HD: Antibody-induced modulation of CD26 surface expression Immunology 84:595-600, 1995.
8. Shimizu Y, Shaw S: Lymphocyte interactions with extracellular matrix. FASEB J 5:2292-2299, 1991.
9. Naquet P, Vivier I, Gorvel JP, Brekelmans P, Barad M, Bernard AM, Pierres M: Activation of mouse T lymphocytes by a monoclonal antibody to a developmentally regulated surface aminopeptidase. Immunol Rev 111:177-193, 1989.
10. Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C: Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol 147:2514-2517, 1991.
11. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C: Direct association of adenosine deaminase with a T cell activation antigen CD26. Science 261:466-469, 1993.
12. Schon E, Jahn S, Kiessig HU, Demuth K, Neubert A, Barth R, Baehr V, Ansorge S: The role of dipeptidyl peptidase IV in human T lymphocyte activation inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 17:1821-1826, 1987.
13. Buhling F, Junker U, Reinhold D, Neubert K, Jager L, Ansorge S: Functional role of CD26 on human B lymphocytes. Immunol Lett 45:47-51, 1995.
14. Buhling F, Dunz D, Reinhold D, Ulmer AJ, Ernst M, Flad HD, Ansorge S: Expression and functional role of dipeptidyl peptidase IV on human natural killer cells. Nat Immun 13:270-279, 1994.
15. Martin M, Huguet J, Centelles JJ, Franco R: Expression of ectoadenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex J Immunol 155:4630-4643, 1995.
16. Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C: Comitogenic effect of solid phase immunobilized anti-IF7 on human CD4 T cell activation via CD3 and CD2 pathways. J Immunol 144:4092-4100, 1990.
17. Bednarczyk J, Carroll SM, Marin C, McIntyre B: Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation. J Cell Biochem 46:206-218, 1991.
18. Ruiz P, Nassiri M, Steele B, Viciana AL: Cytofluorographic evidence that thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny and apoptotic status. Cytometry 23:322-329, 1996.
19. Bauvois B: Murine thymocytes possess specific cell surface-associated exoaminopeptidase activities: Preferential expression by immature CD4-CD8-subpopulation. Eur J Immunol 20:459-468, 1990.
20. Tanaka T, Kameoka J, Yaron A. Schlossman SF, Morimoto C The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90:4586-4590, 1993.
21. Carbone A, Gloghini A, Zagonel V, Aldinucci D, Gattei V, Degan M, Improta S, Sorio R, Monfardini S, Pinto A: The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias Blood 86:4617-4626, 1995.
22. Kondo S. Kotani T, Tamura K, Aratke Y, Uno H, Tsubouchi H, Inoue S, Niho Y, Ohtaki S: Expression of CD26/dipeptidyl peptidase IV in adult T cell leukemia/lymphoma (ATLL). Leuk Res 20:357-363, 1996
23. Carbone A, Gloghini A, Zagonel V, Pinto A: An update on the diagnostic relevance of CD26 antigen expression in CD30 positive anaplastic large cell lymphomas. Hum Pathol 26:1169-1170, 1995.
24. Garcia-Sanchez F, Menarguez J, Cristobal E, Cantalejo A, Gil J, Algara P, Vicario JL: Hepatosplenic gamma-delta T-cell malignant lymphoma: Report of the first case in childhood, including molecular minimal residual disease follow-up. Br J Haematol 90:943-946, 1995.
25. Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES.: Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gamma-delta T-cell origin. Blood 88:4265-4274, 1996.
26. Emil JF, Boulland ML, Haioun C, Kanavaros P, Petrella T, Delfau-Larue MH, Bensussan A, Farcet JP, Gaulard P: CD5- CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 87:1466-1473, 1996.
27. Assfalg-Machleidt I, Rothe G, Klingel S, Banati R, Mangel WF, Valt G, Machleidt W: Membrane permeable fluorogenic rhodamine substrates for selective determination of cathepsin L. Biol Chem Hoppe Seyler 373:433-440, 1992.
28. Leytus SP, Patterson WL, Mangel WF: New class of sensitive and selective fluorogenic substrates for serine proteinases. Biochem J 215:253-260, 1983.
29. Krishan A: Flow cytometric studies on intracellular drug resistance. In: Techniques in Cell Cycle Analysis, Gray JW, Darzynkiewicz Z (eds): Clifton, NJ: Humana Press, 1997, pp 337-366.
30. Alhanaty E, Shaltiel S: Limited proteolysis of the catalytic subunit of cAMP-dependent protein kinase: A membranal regulatory device 656. Biochem Biophys Res Commun 89:323-332, 1979.
31. Mundy DI, Strittmatter WJ: Requirement for metalloendoprotease in exocytosis. Evidence in mast cells and adrenal chromaffin cells. Cell 40:645-656, 1985.
32. Di Stefano JF, Beck G, Lane B, Zucker S: Role of tumor cell membrane-bound serine proteases in tumor-induced target cytolysis, Cancer Res 42:207-218, 1982.
33. Scholz W, Mentlein R, Heymann E. Feller AC, Ulmer AJ, Flad HD: Interleukin 2 production by human T lymphocytes identified by antibodies to dipeptidyl peptidase IV. Cell Immunol 93:199-211. 1985.
34. Morimoto C, Schlossman SF: CD26: A key costimulatory molecule on CD4 memory T cells. Immunologist 2:4-7, 1994.
35. Ruiz P, Hao L, Zucker K, Zacharievich N, Viciana AV, Shenkin M, Miller J: Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status. Transplant Immunol 5:152-161, 1997.